China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)

SHE:300294 Revenue

China Resources Boya Bio-pharmaceutical Group Co.,Ltd had revenue of 322.43M CNY in the quarter ending June 30, 2026, a decrease of -31.67%. This brings the company's total for the last twelve months to 1.69B, down -8.23% year-over-year. In the year 2025, China Resources Boya Bio-pharmaceutical Group Co.,Ltd had annual revenue of 2.06B with 18.69% growth. That makes China Resources Boya Bio-pharmaceutical Group Co.,Ltd the 15,693rd largest company in the world by revenue and 2,815th in China.

• Revenue (ttm): 1.69B
• Revenue Growth: -8.23%
• P/S Ratio: 4.10
• Revenue / Employee: 870.50K
• Employees: 1,947
• Market Cap: 7.07B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Blood Products Business 1.67B 81.2%
• Pharmaceutical Distribution Business 197.91M 9.6%
• Biochemical Pharmaceutical Product 181.66M 8.8%
• Other Business 8.49M 0.4%

Fiscal year ended Dec 31, 2025 See the full SHE:300294 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.06B	324.18M	18.69%
Dec 31, 2024	1.73B	-917.08M	-34.58%
Dec 31, 2023	2.65B	-106.72M	-3.87%
Dec 31, 2022	2.76B	108.17M	4.08%
Dec 31, 2021	2.65B	137.49M	5.47%

Data Source: S&P Global Market Intelligence Last updated: Aug 21, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error